Please wait while we open this resource.
K
Guidelines & protocols
FRAMEWORK FOR THE PHARMACOLOGICAL TREATMENT OF OBESITY AND ITS COMPLICATIONS FROM THE EUROPEAN ASSOCIATION FOR THE STUDY OF OBESITY (EASO): 2026 UPDATE
European Association for the Study of Obesity (EASO)
PDF20265 pages749 KB
The 2026 update of the EASO framework incorporates findings from a systematic literature review and network meta-analysis of 62 randomized controlled trials (RCTs) focused on obesity management medications (OMMs). It emphasizes the rapid advancements in obesity pharmacotherapy, particularly the emergence of incretin-based therapies. The document aims to assist clinicians in personalizing treatment approaches based on the latest evidence regarding weight loss and obesity-related complications.
No account needed
Ask this resource
Answers use this document only.
More like this
Resources from the same specialty and type. Curated links will replace these when added.
Clinical Resources
Documents that extend or complement this resource.
Uganda Diabetes Management Guidelines – Summarised (2026)
Same clinical topic · Endocrinology
Kiruddu DKA guidelines
Same clinical topic · Endocrinology
Pharmacotherapy for Obesity Management: 2025 Guidelines
Same clinical topic · Endocrinology
Management of DKA
Same clinical topic · Endocrinology
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGY CONSENSUS STATEMENT ALGORITHM FOR MANAGEMENT OF ADULTS WITH TYPE 2 DIABETES — 2026 UPDATE
Same clinical topic · Endocrinology
GUIDELINES FOR DIAGNOSIS AND TREATMENT OF CONGENITAL HYPOTHYROIDISM
Same clinical topic · Endocrinology
2026 ETA GUIDELINE ON INTERFERENCE IN IMMUNOASSAY MEASUREMENTS USED IN ASSESSMENT OF THYROID FUNCTION
Same clinical topic · Endocrinology
CANADIAN ADULT OBESITY CLINICAL PRACTICE GUIDELINE: PHARMACOTHERAPY FOR OBESITY MANAGEMENT IN ADULTS
Same clinical topic · Endocrinology
Nutritional Management of Diabetes SOP (2)
Same clinical topic · Endocrinology